Screener
Edgewise Therapeutics, Inc. EWTX Total Current Assets
Total Current Assets at other companies
Other financials
Where this comes from
Reported directly by Edgewise Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AssetsCurrent.
The source filing: Edgewise Therapeutics, Inc.’s 10-Q, filed May 7, 2026.
- Filed
- May 7, 2026, 8:09 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001104659-26-056713
| Assets | As of / March 31, 2026 / (unaudited) | As of / December 31, 2025 |
|---|---|---|
| Cash and cash equivalents | $33,211 | $61,148 |
| Marketable securities, available for sale | 466,351 | 468,961 |
| Prepaid expenses and other assets | 10,230 | 13,276 |
| Total current assets | 509,792 | 543,385 |
| Property and equipment, net | 7,396 | 7,831 |
| Operating lease right-of-use asset | 1,334 | 1,387 |
| Total assets | $518,522 | $552,603 |
| Liabilities and stockholders' equity |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Edgewise Therapeutics, Inc.'s total current assets?
- Edgewise Therapeutics, Inc. (EWTX) reported total current assets of $509.79M in Q1 2026.
- How has Edgewise Therapeutics, Inc.'s total current assets changed year-over-year?
- Edgewise Therapeutics, Inc.'s total current assets increased by 15.0% year-over-year, from $443.18M to $509.79M.
- What is the long-term trend for Edgewise Therapeutics, Inc.'s total current assets?
- Over 5 years (2020 to 2025), Edgewise Therapeutics, Inc.'s total current assets has grown at a 33.2% compound annual growth rate (CAGR), from $129.65M to $543.39M.
- What does total current assets mean?
- The sum of all assets expected to be converted to cash or consumed within one year — cash, receivables, inventory, and prepaid expenses.
Ask your AI about Edgewise Therapeutics, Inc.'s total current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude